MEDITERA TIBBI MALZEMENAYI VE TICARET AS's quarterly market cap
declined
from Sep. 2025 (₺3,808 Mil) to Dec. 2025 (₺3,422 Mil) and
declined
from Dec. 2025 (₺3,422 Mil) to Mar. 2026 (₺2,573 Mil).
MEDITERA TIBBI MALZEMENAYI VE TICARET AS's annual market cap
increased
from Dec. 2023 (₺3,276 Mil) to Dec. 2024 (₺6,295 Mil) but then
declined
from Dec. 2024 (₺6,295 Mil) to Dec. 2025 (₺3,422 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Enterprise Value for Today is ₺2,323 Mil.
MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
MEDITERA TIBBI MALZEMENAYI VE TICARET AS Market Cap Related Terms
MEDITERA TIBBI MALZEMENAYI VE TICARET AS Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEDITERA TIBBI MALZEMENAYI VE TICARET AS Market Cap Chart
MEDITERA TIBBI MALZEMENAYI VE TICARET AS Annual Data
For the Medical Devices subindustry, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MEDITERA TIBBI MALZEMENAYI VE TICARET AS Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Market Cap distribution charts can be found below:
* The bar in red indicates where MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Market Cap falls into.
MEDITERA TIBBI MALZEMENAYI VE TICARET AS Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) has a Market Cap of ₺2,744 Mil as of Jul. 02, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on MEDITERA TIBBI MALZEMENAYI VE TICARET AS and its competitors. According to the industry distribution chart, MEDITERA TIBBI MALZEMENAYI VE TICARET AS ranks #514 out of 869 companies in the Medical Devices & Instruments industry, placing it in the top 59.1%.
Is MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Market Cap too high?
MEDITERA TIBBI MALZEMENAYI VE TICARET AS's current Market Cap is ₺2,744 Mil. Based on the distribution chart, MEDITERA TIBBI MALZEMENAYI VE TICARET AS ranks #514 out of 869 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, MEDITERA TIBBI MALZEMENAYI VE TICARET AS has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, MEDITERA TIBBI MALZEMENAYI VE TICARET AS ranks #514 out of 869 companies for Market Cap. This places MEDITERA TIBBI MALZEMENAYI VE TICARET AS in the lower half of its industry. The industry median Market Cap is 119.28. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 119.28, based on 869 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on MEDITERA TIBBI MALZEMENAYI VE TICARET AS and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 119.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MEDITERA TIBBI MALZEMENAYI VE TICARET AS's current Market Cap is ₺2,744 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MEDITERA TIBBI MALZEMENAYI VE TICARET AS stock overvalued right now?
Based on GuruFocus' analysis, MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) is currently considered Significantly Undervalued. The stock's GF Value™ is ₺43.57, compared to a current price of ₺28.92 — trading 33.6% below its estimated fair value. The current Market Cap is ₺2,744 Mil. MEDITERA TIBBI MALZEMENAYI VE TICARET AS's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR), the current Market Cap is ₺2,744 Mil as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) Overvalued in 2026?
Based on GuruFocus' analysis, MEDITERA TIBBI MALZEMENAYI VE TICARET AS stock appears to be undervalued.
The current stock price of ₺28.92 is trading 33.6% below its estimated GF Value™ of ₺43.57.
GuruFocus considers MEDITERA TIBBI MALZEMENAYI VE TICARET AS to be Significantly Undervalued.
Key valuation signals for IST:MEDTR:
Market Cap: ₺2,744 Mil
GF Value™: ₺43.57 vs. price of ₺28.92 (33.6% below fair value)
No single metric tells the full story. See the IST:MEDTR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MEDITERA TIBBI MALZEMENAYI VE TICARET AS Business Description
MEDITERA TIBBI MALZEME SANAYI VE TICARET AS is engaged in the manufacture of anesthesia and intensive care circuits, the installation, operation, and design of oncology drug preparation and delivery systems, production, sales, and technical service of infusion pumps and sets, and the manufacture of biocidal products.
82GF Score
Get the complete analysis for IST:MEDTR
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:MEDTR has been successfully added to your 
